BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7681703)

  • 1. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
    Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
    Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
    Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
    Piedras J; López-Karpovitch X
    Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
    Hillmen P; Hows JM; Luzzatto L
    Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
    Fujioka S; Yamada T
    Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
    Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
    Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
    Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
    Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
    Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
    Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
    Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
    Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PIG-anchoring defect in NK lymphocytes of PNH patients.
    Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
    Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
    Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
    Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
    Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
    Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
    Hall SE; Rosse WF
    Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of the PNH defect by GPI-anchored protein transfer.
    Sloand EM; Maciejewski JP; Dunn D; Moss J; Brewer B; Kirby M; Young NS
    Blood; 1998 Dec; 92(11):4439-45. PubMed ID: 9834251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.